News
The idea of incorporating hemp or cannabis in your oral routine may not be a familiar inference. But recent data shows that cannabinoids could become a staple in the dental field in the years ahead. Some of the leading manufacturers of toothpaste have taken note of research showing that CBD and the beneficial antimicrobial properties that are relevant to dental health.
A 2020 study conducted by researchers in Belgium showed that “cannabinoids were more effective in reducing the bacterial colony count in dental plaques as compared to well-established synthetic oral care products, such as Oral B and Colgate.” Better than Oral B? That can’t be right. Right?
The University of South Carolina has a cannabinoid science lab led by Prakash Nagarkatti. Nagarkatti and his team are currently pioneering investigations into the ECS, the gut microbiome, and disease. They may even have discovered a clue for treating one of the most harmful complications of COVID-19 in some patients.
Frontiers in Pharmacology, a journal with a study done in June, 2020 explored this ECS manipulation by administering THC to mice affected with a form of acute respiratory distress syndrome (ARDS). The results were astounding-Nagarkatti and colleagues demonstrated that the application of THC completely healed the ARDS in the laboratory mice.
